Table 3 Cox proportional hazard model analysis for risk of RA.
After propensity score matching | ||
|---|---|---|
aHRa (95% CI) | p-value | |
H. pylori-infected group (ref: control) | 1.45 (1.34–1.56) | < 0.0001 |
Index year | ||
2001–2005 | Reference | |
2006–2010 | 0.74 (0.67–0.81) | < 0.0001 |
2011–2016 | 0.63 (0.54–0.74) | < 0.0001 |
Sex | ||
Female | Reference | |
Male | 0.44 (0.41–0.48) | < 0.0001 |
Age | ||
< 30 | Reference | |
30–44 | 2.24 (1.81–2.79) | < 0.0001 |
45–64 | 3.77 (3.06–4.64) | < 0.0001 |
≥ 65 | 4.2 (3.35–5.28) | < 0.0001 |
Urbanization | ||
Urban | 0.9 (0.82–0.99) | 0.0246 |
Sub-urban | Reference | |
Rural | 1.06 (0.91–1.24) | 0.4325 |
Insurance property | ||
Government employee insurance | 1.03 (0.89–1.18) | 0.7329 |
Labor insurance | Reference | |
Farmer/fisherman/water resources employee insurance | 0.91 (0.8–1.03) | 0.1363 |
Low-income family | 1.26 (0.67–2.34) | 0.4744 |
Local insurance by government | 1.08 (0.96–1.21) | 0.1969 |
Others | 1.1 (0.82–1.48) | 0.5406 |
Comorbidity (ref: without comorbidity) | ||
Hypertension | 1.05 (0.96–1.16) | 0.2960 |
Diabetes mellitus | 0.89 (0.78–1.01) | 0.0756 |
Hyperlipidemia | 1.12 (1–1.25) | 0.0528 |
Asthma | 1 (0.81–1.23) | 0.9986 |
Cerebrovascular disease | 0.94 (0.77–1.14) | 0.5331 |
Chronic pulmonary diseases | 1.24 (1.08–1.42) | 0.0019 |
Kidney disease | 1.38 (1.14–1.67) | 0.0009 |
Liver disease | 1.3 (1.18–1.43) | < 0.0001 |
Pneumonia | 1.38 (1.1–1.73) | 0.0057 |
Osteoporosis | 1.38 (1.19–1.6) | < 0.0001 |
Sjogren syndrome | 2.15 (1.5–3.1) | < 0.0001 |
Systemic lupus erythematosus | 3.31 (1.95–5.64) | < 0.0001 |
Ankylosing spondylitis | 2.74 (1.86–4.04) | < 0.0001 |